Puberty blockers and gender-affirming hormones rarely prescribed to transgender youth
A recent study published in JAMA Pediatrics, found that fewer than 1 in 1,000 U.S. adolescents with commercial insurance received gender-affirming medications, such as puberty blockers or hormones, over a five-year period.
The study analyzed a large insurance claims database and found that only 926 adolescents received puberty blockers and 1,927 received hormones from 2018 to 2022.
The findings suggest that the use of these medications is not as widespread as some might believe. The study also highlighted that no patients under age 12 were prescribed hormones, indicating cautious medical practices.
Fewer than 1 in 1,000 US adolescents receive gender-affirming medications, researchers find
Some say too many transgender kids are given hormones. Data finds otherwise.
Dr. Rachel Levine focused on her job at HHS. Still, anti-trans politics followed her
Transgender Georgians and allies brace for another year of culture wars in state legislature
In 2021, at the age of 59, Ms. Steele, a comedy writer and the former head writer of “Saturday Night Live,” emailed friends that she had decided to transition to live as a woman.
Archived.
McDonald’s is the latest company to roll back diversity goals
Houston: Transgender teen speaks out after brutal attack on METRO bus
Federal Court Rules In Favor of Forcibly Detransitioning Transgender Inmates In Florida
A source of transgender inspiration from TikTok.
